What is the current stock price of CinCor Pharma, Inc. (CINC)?

As of the latest market data, CinCor Pharma, Inc. (CINC) is trading at $29.06. The stock has seen a loss of 0.00% today.

Does CinCor Pharma, Inc. (CINC) pay a dividend?

Based on current data, CinCor Pharma, Inc. does not have a confirmed active dividend policy.

What is the market cap of CinCor Pharma, Inc.?

The current market capitalization of CinCor Pharma, Inc. (CINC) is approximately unavailable.

CINC

CinCor Pharma, Inc.·Healthcare

29.06

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $10.5352W H: $43.15

Company Profile

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of treatments for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. CinCor Pharma, Inc. has a license agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. The company was incorporated in 2018 and is headquartered in Boston, Massachusetts.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2022-01-07

Beta

0.00

Websitewww.cincor.com↗